Riskpilot← Back to searchSign inGet full accessSF Medical ApS
APSActiveCVR 36964901Skodsborg Strandvej 125AWholesale of pharmaceutical and medical goods · NACE 4646Est. 2015— employees
Revenue 2025
DKK -60K
-25% vs 2024
EBITDA margin
100.0%
+73% vs 2024
Equity ratio
35.0%
Financial strength
Net profit 2025
DKK 4K
+102% vs 2024
| Revenue | DKK -60K | -25% |
| EBITDA | DKK -60K | +73% |
| Net profit | DKK 4K | +102% |
| Total assets | DKK 457K | +17% |
| Equity | DKK 160K | +2% |
| Employees | — | — |
Legal name
SF Medical ApS
CVR number
36964901
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. juli 2015
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er import samt køb og salg af medicinsk udstyr herudover erhvervelse og besiddelse af kapitalandele i danske og udenlandske erhvervsvirksomheder, finansiering, investeringsvirksomhed samt direkte eller indirekte at drive virksomhed, der efter ledelsens skøn er forbundet hermed.
Address
Skodsborg Strandvej 125A
Phone
+4545560030
Email
info@sfmedical.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -156 | 73 | 148 | -67 | -150 | -209 | -251 | -17 | -81 | -60 |
| Staff expenses | -70 | -102 | -512 | -485 | -315 | -192 | -182 | -288 | -144 | -0 |
| EBITDA | -226 | -30 | -364 | -552 | -465 | -401 | -434 | -375 | -225 | -60 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -226 | -30 | -364 | -552 | -465 | -401 | -434 | -375 | -225 | -60 |
| Net financials | -11 | -13 | -36 | -30 | -28 | -26 | -24 | -35 | -3 | -7 |
| Profit before tax | -133 | -24 | -226 | -582 | -493 | -427 | -458 | -410 | -228 | -68 |
| Tax | 52 | 9 | 87 | -127 | -107 | -94 | -101 | -90 | 7 | -71 |
| Net profit | -185 | -33 | -313 | -455 | -385 | -333 | -357 | -320 | -234 | 4 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 235 | 434 | 647 | 633 | 644 | 529 | 535 | 405 | 389 | 457 |
| Equity | -135 | -168 | 69 | 64 | 79 | 96 | -261 | 390 | 156 | 160 |
| Long-term debt | 0 | 0 | 404 | 506 | 550 | 418 | 772 | 0 | 211 | 270 |
| Short-term debt | 370 | 602 | 174 | 63 | 15 | 15 | 24 | 15 | 23 | 27 |
| Total debt | 370 | 602 | 578 | 569 | 565 | 433 | 796 | 15 | 233 | 297 |
EBITDA margin
-6039600.0%
This company
15.8%
Market median
-38225416% vs market
20162025
Equity ratio
35.0%
This company
38.2%
Market median
+8% vs market
20162025
Return on equity
2.3%
This company
18.4%
Market median
-88% vs market
20162025
Net profit margin
368200.0%
This company
8.1%
Market median
+4545579% vs market
20162025
Asset turnover
-0.13×
This company
1.12×
Market median
-112% vs market
20162025
Debt / equity
1.86×
This company
0.62×
Market median
-200% vs market
20162025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-13 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ME Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
LM Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
JO Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MYKLEBUST HOLDING ApS | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MYKLEBUST HOLDING ApS
SF Medical ApS Board members of SF Medical ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Edward Newcomb Burgess | Chief Executive Officer | 0 companies |
| Louise Margrethe Deichmann | Chief Executive Officer | 0 companies |
| Jan Ove Myklebust | Management | 0 companies |
| Flemming Ammentorp Østergaard | Chairman | 0 companies |